Accessibility Menu

Seelos Therapeutics

(OTC) SEELQ

Current Price$0.00
Market Cap$100.00
Since IPO (2019)-100%
5 YearN/A
1 Year+9,900%
1 Month+9,900%

Seelos Therapeutics Financials at a Glance

Market Cap

$100.00

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-208.88 (Low)

Price

$0.00

Volume

3

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

SEELQ News

ETF made of $100 dollar bills

Why Seelos Therapeutics Stock Is Jumping Today

Keith SpeightsJun 1, 2021
A medical professional using a microscope

Why Seelos Therapeutics Dived by 24% Today

Eric VolkmanMay 17, 2021
Thumbs up from businessman

Why Seelos Therapeutics Stock Is Skyrocketing Today

Keith SpeightsMar 12, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Seelos Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

16

CEO

Raj Mehra, PhD, MBA

Website

www.seelostherapeutics.com

SEELQ Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$100.00

Shares Outstanding

1.12M

Volume

3

Avg. Volume

25.839

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Seelos Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,483.24+0.00%
^DJIDJI
$52,900.07+0.01%
^IXICNASDAQ
$25,832.67-0.01%
BTCBitcoin
$62,641.00-0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%

Questions About SEELQ

What is the current price of Seelos Therapeutics?

Seelos Therapeutics is trading at $0.00 per share.

What is the 52-week range for Seelos Therapeutics?

Over the past 52 weeks, Seelos Therapeutics has traded between $0.00 and $0.01.

How much debt does Seelos Therapeutics have?

As of the most recent reporting period, Seelos Therapeutics reported total debt of $14.23M.

How much cash does Seelos Therapeutics have on hand?

Seelos Therapeutics reported $3.00M in cash and cash equivalents in its most recent financial results.

What is Seelos Therapeutics’s dividend yield?

Seelos Therapeutics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services